A. Tam, R. T. Raines / Bioorg. Med. Chem. 17 (2009) 1055–1063
1061
6.47 (dq, J = 0.963 ppm, 7.1 Hz, 1H), 3.98–3.91 (m, 8H),
2.56 (s, 12H), 2.53 (s, 12H), 1.80–0.80 (m, 15H) ppm;
13C NMR (CDCl3, 100.6 MHz) d 140.27, 137.53 (d,
J = 9.8 Hz), 133.05 (d, J = 10.0 Hz), 125.69 (d,
J = 56 Hz), 67.12, 51.38 (d, J = 50.9 Hz) ppm; 31P
NMR (CDCl3, 161 MHz) d ꢂ1.12 ppm; MS (ESI) m/z
507.4447 (MNa+ [C24H54B5N4PNa+] = 507.4444).
under reduced pressure, and the residue was purified
by flash chromatography (silica gel, 10% v/v ethyl ace-
tate and 20% v/v hexanes in CH2Cl2) to give phos-
phine–borane complex 19 as a white solid in 56%
yield. 1H NMR (CDCl3, 400 MHz)
d 7.91 (d,
J = 1.1 Hz, 2H), 7.88 (d, J = 1.1 Hz, 2H), 7.74 (s, 2H),
3.93 (q, J = 13.7 Hz, 8H), 3.73 (d, J = 6.3 Hz, 2H),
2.58 (s, 12H), 2.57 (s, 12H), 2.23 (s, 3H), 2.00–1.50 (m,
15H) ppm; 13C NMR (CDCl3, 100.6 MHz) d 192.70,
140.46, 137.24 (d, J = 9.5 Hz), 132.84 (d, J = 10.2 Hz),
126.98 (d, J = 54.9 Hz), 67.94, 52.04, 51.09, 30.28
24.21 (d, J = 34.9 Hz) ppm; 31P NMR (CDCl3,
4.2.11. BH3ÆAcSCH2P(C6H4-m-CH2NMe2)2 (17). Phos-
phine–borane complex 13 (81 mg, 0.24 mmol) was dis-
solved in dry DMF (2.5 mL) under Ar(g) and cooled
to 0 °C. NaH (5.7 mg, 0.24 mmol) was added slowly,
and the mixture was stirred at 0 °C until bubbling
ceased. Bromide 16 (40 mg, 0.24 mmol) was then added,
and the resulting mixture was allowed to warm to room
temperature and stirred for 12 h. Solvent was removed
under reduced pressure, and the residue was purified
by flash chromatography (silica gel, 2% v/v ethyl acetate
and 28% hexanes in CH2Cl2) to give phosphine–borane
161 MHz) d 18.74 ppm; MS (ESI) m/z 590.4409
(MNa+ [C27H58B5N4OPSNa+] = 590.4427).
4.2.14. AcSCH2P(C6H4-m-CH2NMe2)2 (20). Phos-
phine–borane complex 17 (100 mg, 0.23 mmol) was dis-
solved in toluene (2 mL) under Ar(g). DABCO (84 mg,
0.74 mmol) was added, and the resulting solution was
heated to 40 °C for 4 h. The solvent was removed under
reduced pressure, and the residue was purified by flash
chromatography (silica gel, 20% v/v MeOH in CH2Cl2)
to give phosphinothioester 20 as a colorless oil in 95%
yield. 1H NMR (CDCl3, 400 MHz) d 7.38–7.29 (m,
8H), 3.53 (d, J = 3.7 Hz, 2 H), 3.41 (s, 4H), 2.28 (s,
3H), 2.22 (s, 12H) ppm; 13C NMR (CDCl3,
100.6 MHz) d 194.74, 138.88 (d, J = 4.7 Hz), 136.91 (d,
J = 13.4 Hz), 133.83 (t, J = 19.2 Hz), 131.56, 130.17 (d,
J = 29.9 Hz), 128.63 (d, J = 32.2 Hz), 64.15, 45.63,
30.76, 20.96 (d, J = 23.5 Hz) ppm; 31P NMR (CDCl3,
161 MHz) ꢂ15.23 ppm.
1
complex 17 as a white solid in 78% yield. H NMR
(CDCl3, 400 MHz) d 7.78–7.73 (m, 4H), 7.57–7.49 (m,
4H), 3.95 (d, J = 2.4 Hz, 4H), 3.73 (d, J = 6.3 Hz, 2H),
2.53 (d, J = 6.3 Hz, 12H), 2.25 (s, 3H), 2.20–0.60 (m,
9H) ppm; 13C NMR (CDCl3, 100.6 MHz) d 192.88,
136.42 (d, J = 9.5 Hz), 135.93, 133.41 (d, J = 9.4 Hz),
132.53 (d, J = 9.9 Hz), 129.03 (d, J = 10.0 Hz), 127.73
(d, J = 54.6 Hz), 67.45, 53.65, 30.18, 23.70 (d,
J = 35.7 Hz) ppm; 31P NMR (CDCl3, 161 MHz) d
19.97 ppm; MS (ESI) m/z 453.2595 (MNa+
[C21H38B3N2OPSNa+] = 453.2614).
4.2.12. BH3ÆAcSCH2P(C6H4-m-CH2CH2NMe2)2 (18).
Phosphine–borane complex 14 (100 mg, 0.27 mmol)
was dissolved in dry DMF (3 mL) under Ar(g) and
cooled to 0 °C. NaH (6.5 mg, 0.27 mmol) was added
slowly, and the mixture was stirred at 0 °C until
bubbling ceased. Bromide 16 (46 mg, 0.27 mmol) was
then added, and the resulting mixture was allowed to
warm to room temperature and stirred for 12 h. Solvent
was removed under reduced pressure, and the residue
was purified by flash chromatography (silica gel, 2%
v/v ethyl acetate and 28% hexanes in CH2Cl2) to give
phosphine–borane complex 18 as a white solid in 75%
4.2.15. AcSCH2P(C6H4-m-CH2CH2NMe2)2 (21). Phos-
phine–borane complex 18 (38 mg, 0.096 mmol) was dis-
solved in toluene (1 mL) under Ar(g). DABCO (35 mg,
0.30 mmol) was added, and the resulting solution was
heated to 40 °C for 4 h. The solvent was removed under
reduced pressure, and the residue was purified by flash
chromatography (silica gel, 20% v/v MeOH in CH2Cl2)
to give phosphinothioester 21 as a colorless oil in 95%
yield. 1H NMR (CDCl3, 400 MHz) d 7.28–7.20 (m,
8 H), 3.50 (d, J = 3.4 Hz, 2H), 2.80–2.76 (m, 4H),
2.57–2.53 (m, 4H), 2.32 (s, 12H), 2.30 (s, 3H) ppm;
13C NMR (CDCl3, 100.6 MHz) d 194.87, 140.54 (d,
J = 7.7 Hz), 136.96 (d, J = 14.2 Hz), 133.25 (d,
J = 22.8 Hz), 130.48 (d, J = 16 Hz), 129.70, 128.78 (d,
J = 4.9 Hz), 64.26, 46.94, 45.47, 34.25, 25.99 (d,
J = 23.4 Hz) ppm; 31P NMR (CDCl3, 161 MHz) d
ꢂ14.99 ppm.
yield. 1H NMR (CDCl3, 400 MHz)
d 7.56–7.52
(m, 4H), 7.45–7.38 (m, 4H), 3.71 (d, J = 6.8 Hz, 2H),
3.13–3.09 (m, 4H), 2.97–2.92 (m, 4H), 2.67 (d,
J = 2.7 Hz, 12H), 2.28 (s, 3H), 2.40–0.60 (m, 9H) ppm;
13C NMR (CDCl3, 100.6 MHz) d 193.34, 139.26 (d,
J = 9.9 Hz), 132.77 (d, J = 11.7 Hz), 132.58, 130.96 (d,
J = 8.3 Hz), 129.54 (d, J = 10.0 Hz), 128.23 (d,
J = 55.9 Hz), 65.83, 52.05, 30.95, 30.32, 23.81 (d,
J = 35.3 Hz) ppm; 31P NMR (CDCl3, 161 MHz) d
19.65 ppm; MS (ESI) m/z 481.2918 (MNa+
[C23H42B3N2OPSNa+] = 481.2927).
4.2.16.
AcSCH2P(C6H3-bis-m,m-CH2NMe2)2
(22).
Phosphine–borane complex 19 (59 mg, 0.10 mmol) was
dissolved in toluene (1.5 mL) under Ar(g). DABCO
(60 mg, 0.54 mmol) was added, and the resulting solu-
tion was heated to 40 °C for 4 h. The solvent was re-
moved under reduced pressure, and the residue was
purified by flash chromatography (silica gel, 20% v/v
MeOH in CH2Cl2 with 1% v/v NEt3) to give phosphino-
4.2.13. BH3ÆAcSCH2P(C6H3-bis-m,m-CH2NMe2)2 (19).
Phosphine–borane complex 15 (86 mg, 0.18 mmol) was
dissolved in dry DMF (2 mL) under Ar(g) and cooled
to 0 °C. NaH (4.3 mg, 0.18 mmol) was added slowly,
and the mixture was stirred at 0 °C until bubbling
ceased. Bromide 16 (30 mg, 0.18 mmol) was then added,
and the resulting mixture was allowed to warm to room
temperature and stirred for 12 h. Solvent was removed
1
thioester 22 as a colorless oil in 91% yield. H NMR
(CDCl3, 400 MHz) d 7.28–7.21 (m, 6H), 3.53 (d,
J = 3.7 Hz, 2H), 3.39 (m, 8H), 2.27 (s, 3H), 2.21 (s,
24H) ppm; 13C NMR (CDCl3, 100.6 MHz) d 194.82,
139.07 (d, J = 7.4 Hz), 136.88 (d, J = 14.6 Hz), 132.48